It is worth mentioning that the expression of PD-L1 on tumor cells can be induced as an adaptive response to antitumor immunity, but the injected CP-bi-apt also can be used as an immune checkpoint inhibitor to block up-regulated PD-L1, and thus, the function of NK cells can be restored, which promotes robust antitumor immune response. This evidence concerns the gene CD274 and neoplasm.